China
Africa
Explore chapters and articles related to this topic
Intrauterine fetal death
Published in David M. Luesley, Mark D. Kilby, Obstetrics & Gynaecology, 2016
The onset of lactation often catches women by surprise and is a source of considerable distress when it starts in earnest at about 48 hours. Although not all women need or want lactation suppression, discussion should take place so that advice can be given about how to cope. For some women, simply a good supportive bra, NSAIDs if there is discomfort, and time will be enough. However, about a third of women experience distressing breast pain and so pharmacological measures should be offered to all suitable women. A single dose (1 mg) of cabergoline, a long-acting dopamine agonist, is highly effective. Dopamine agonists for the inhibition of lactation should not be used in women with preeclampsia or hypertension [B].7
Postpartum Problems (The Puerperium), Including Neonatal Problems – Answers
Published in Rekha Wuntakal, Madhavi Kalidindi, Tony Hollingworth, Get Through, 2014
Rekha Wuntakal, Madhavi Kalidindi, Tony Hollingworth
If suppression of lactation is not done with bromocriptine-related preparations in women with intrauterine fetal death or stillbirths, breast engorgement occurs during the first day or two. The breasts become tender, firm and distended with dilated veins. Fever can occur in about 15% of women. Supportive measures and expression of breast milk are the mainstays of treatment while lactation suppression becomes effective.
Information on level of drugs into breastmilk
Published in Wendy Jones, Breastfeeding and Medication, 2013
Cabergoline Brand name: Dostinex US brands: Dostinex Australian brands: Dostinex Cabergoline is a long-acting synthetic ergot alkaloid that produces a dopamine agonist effect. It is recommended in several European countries to inhibit or suppress physiological lactation post-partum. Standard literature still recommends caution in routine use. There is no data on transfer into breastmilk reported. Side effects are similar to those of bromocriptine – dizziness, nausea, postural hypotension, drowsiness together with some gastro-intestinal disturbances. The dose to inhibit lactation is 1 mg as a single dose on the first day post-partum, or 0.25 mg every 12 hours for 2 days (Webster 1996). Avoid breastfeeding if lactation suppression fails (BNF). Since Dostinex is a special pack of eight tablets each containing 500 g, care must be take to clarify the dose regimen. It completely and irreversibly suppresses lactation so the mother should be given every opportunity to consider her decision before taking the tablets. Avoid use during breastfeeding as may reduce or halt milk production.
“I was afraid my baby would be upset with me” – women living with HIV’s accounts going through non-breastfeeding in São Paulo, Brazil
Published in AIDS Care, 2021
Beatriz da Costa Thome, Regina Célia de Menezes Succi, James Pfeiffer
Similar to our findings, other studies carried out in Brazil reported on women’s negative feelings around their HIV diagnosis confounding their experiences of non-breastfeeding (MacCarthy et al., 2013; Moreno et al., 2006; Padoin & Souza, 2008). Previous research showed that women shared a sense of acceptance that finally followed the initial rage against receiving a positive HIV test result (Padoin & Souza, 2008). The same study reported that some women had had previous experiences with breastfeeding other children, prior to their HIV diagnosis, and had weaned them early for various reasons such as going back to work among others. Nevertheless, not being “allowed” to breastfeed because of their HIV status had a heavier effect on them (Padoin & Souza, 2008), similar to some narratives in our study. In our study, as well as previously reported, narratives of sadness and unfulfillment around not breastfeeding and lactation suppression methods were common, as well as the practice of hiding the reason behind not breastfeeding from relatives(Moreno et al., 2006; Padoin & Souza, 2008). As examples of possible coping mechanisms, denial and compensation have been reported at least in one previous study: some women would “forget” they could not breastfeed and would prepare for it during pregnancy, while others said that since they could not breastfeed they would give the baby more affection, trying to minimize their sense of guilt (Hebling & Hardy, 2007).
Dietary management of infants and young children with feeding difficulties and unsatisfactory weight gain using a nutritionally complete hypercaloric infant formula. practical considerations from clinical cases
Published in Postgraduate Medicine, 2021
Małgorzata Matuszczyk, Paulina Mika-Stępkowska, Agnieszka Szmurło, Marcin Szary, Mirosław Perlinski, Jarosław Kierkuś
A few days after introducing the high-energy polymeric formula, the nutrition team was sought for additional consultation due to poor tolerance of the recommended formula manifested by increased retching and vomiting. Therefore, the formula was replaced with a complete, hypercaloric whey peptide-based diet. The feeding method was also modified by extending each serving time to 30 minutes. Due to lactation suppression, breast milk was replaced with standard infant formula. Previously recommended servings were maintained.